Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer.
暂无分享,去创建一个
Karen R. Sepucha | G. Sledge | K. Sepucha | D. Northfelt | A. Partridge | R. Swaby | B. Schneider | K. Miller | A. O'neill | C. Dang | C. Motley
[1] Angela Fagerlin,et al. The role of perceived benefits and costs in patients’ medical decisions , 2014, Health expectations : an international journal of public participation in health care and health policy.
[2] B. Coller,et al. Assessing participant-centered outcomes to improve clinical research. , 2013, The New England journal of medicine.
[3] M. Piccart-Gebhart,et al. Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence , 2012, Journal of oncology.
[4] T. Kaptchuk,et al. Participants’ Experiences of Being Debriefed to Placebo Allocation in a Clinical Trial , 2012, Qualitative health research.
[5] E. Perez,et al. A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] B. Biedrzycki. Decision making for cancer clinical trial participation: a systematic review. , 2010, Oncology nursing forum.
[7] P. Ubel,et al. The DECISIONS Study: A Nationwide Survey of United States Adults Regarding 9 Common Medical Decisions , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.
[8] M. Ellis,et al. A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer , 2010, Breast Cancer Research and Treatment.
[9] E. Ang,et al. Anxiety in women with breast cancer undergoing treatment: a systematic review. , 2009, International journal of evidence-based healthcare.
[10] E. Winer,et al. The impact of sharing results of a randomized breast cancer clinical trial with study participants , 2009, Breast Cancer Research and Treatment.
[11] E. Winer,et al. Sharing study results with trial participants: time for action. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] E. Emanuel,et al. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] U. Matulonis,et al. Long-term adjustment of early-stage ovarian cancer survivors , 2007, International Journal of Gynecologic Cancer.
[14] A. Monnier,et al. Decision-making and breast cancer clinical trials: how experience challenges attitudes. , 2007, Contemporary clinical trials.
[15] N. Friedland,et al. The cost of richness: the effect of the size and diversity of decision sets on post-decision regret. , 2007, Journal of personality and social psychology.
[16] E. Winer,et al. Long‐term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer , 2007, Psycho-oncology.
[17] N. Weinstein,et al. Risk perceptions: assessment and relationship to influenza vaccination. , 2007, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[18] G. Sledge. A new age now begins. , 2005, Clinical breast cancer.
[19] J. Kleijnen,et al. Reactions to treatment debriefing among the participants of a placebo controlled trial , 2005, BMC health services research.
[20] S. Edwards,et al. Lay public's understanding of equipoise and randomisation in randomised controlled trials. , 2005, Health technology assessment.
[21] H. Brody,et al. The Clinician-Investigator: Unavoidable but Manageable Tension , 2003, Kennedy Institute of Ethics journal.
[22] D. Lubeck,et al. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE. , 2003, The Journal of urology.
[23] F. Miller,et al. A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials. , 2003, The Hastings center report.
[24] E. Winer,et al. Do patients participating in clinical trials want to know study results? , 2003, Journal of the National Cancer Institute.
[25] S. Joffe,et al. Views of American oncologists about the purposes of clinical trials. , 2002, Journal of the National Cancer Institute.
[26] J. Kleijnen,et al. Informing participants of allocation to placebo at trial closure: postal survey , 2002, BMJ : British Medical Journal.
[27] E. Winer,et al. Informing clinical trial participants about study results. , 2002, JAMA.
[28] S. Goodman,et al. What patients say about medical research. , 1998, IRB.
[29] J. Holland,et al. Quality of life for adult leukemia survivors treated on clinical trials of cancer and leukemia group B during the period 1971‐1988 , 1997, Cancer.
[30] M. Weintraub. Improving the ethics of clinical trials: the case of an 'add-on' study. , 1983, IRB.
[31] D. Miles. Bevacizumab in First-Line Treatment of Metastatic Breast Cancer , 2012, Drugs.
[32] I. Tannock,et al. Placebo effects in oncology. , 2003, Journal of the National Cancer Institute.
[33] J. Holland,et al. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation , 1998, Cancer.